$237 Million is the total value of KNOTT DAVID M's 148 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 61.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HHC | Sell | The Howard Hughes Corporation | $1,610,000 | -43.5% | 13,000 | -49.8% | 0.68% | -40.2% |
STML | Sell | Stemline Therapeutics, Inc. | $1,542,000 | -24.0% | 100,634 | -36.2% | 0.65% | -19.6% |
CPRX | Sell | Catalyst Pharmaceuticals, Inc. | $1,318,000 | -49.4% | 343,347 | -32.8% | 0.56% | -46.4% |
Sell | Intec Pharma Ltd. | $1,126,000 | -47.1% | 259,377 | -10.7% | 0.48% | -44.1% | |
ARNA | Sell | Arena Pharmaceuticals, Inc. | $1,075,000 | -34.6% | 18,332 | -50.0% | 0.45% | -30.8% |
CFFN | Sell | Capitol Federal Financial Inc. | $135,000 | -98.5% | 9,800 | -98.5% | 0.06% | -98.4% |
CUZ | Sell | Cousins Properties | $121,000 | -6.9% | 3,357 | -75.0% | 0.05% | -1.9% |
ALNY | Exit | Alnylam Pharmaceuticals, Inc. | $0 | – | -500 | -100.0% | -0.02% | – |
AFMD | Exit | Affimed N.V. | $0 | – | -16,037 | -100.0% | -0.03% | – |
NUVA | Exit | NuVasive, Inc. | $0 | – | -2,000 | -100.0% | -0.04% | – |
CARA | Exit | Cara Therapeutics Inc | $0 | – | -7,114 | -100.0% | -0.06% | – |
BIIB | Exit | Biogen Inc. | $0 | – | -2,498 | -100.0% | -0.24% | – |
CNCE | Exit | Concert Pharmaceuticals, Inc. | $0 | – | -83,607 | -100.0% | -0.40% | – |
ZGNX | Exit | Zogenix, Inc. | $0 | – | -26,039 | -100.0% | -0.57% | – |
CXW | Exit | CoreCivic, Inc. | $0 | – | -75,000 | -100.0% | -0.58% | – |
DWDP | Exit | DowDupont Inc. | $0 | – | -37,644 | -100.0% | -0.80% | – |
IRDM | Exit | Iridium Communications, Inc. | $0 | – | -113,399 | -100.0% | -1.20% | – |
ORCL | Exit | Oracle Corporation | $0 | – | -150,000 | -100.0% | -3.21% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
Pfizer Inc. | 34 | Q3 2021 | 17.4% |
Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
Apple Inc. | 34 | Q3 2021 | 2.1% |
Microsoft Corporation | 34 | Q3 2021 | 2.3% |
AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
Johnson & Johnson | 34 | Q3 2021 | 0.6% |
Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
Westway Group, Inc. | February 01, 2013 | ? | ? |
FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-12 |
13F-HR | 2021-08-13 |
13F-HR | 2021-05-13 |
13F-HR | 2021-02-12 |
13F-HR | 2020-11-13 |
13F-HR | 2020-08-12 |
13F-HR | 2020-05-13 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-12 |
13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.